ePathScreen, LLC is a medical devices development company that holds patented technology for intelligent, cell recognition software used in cancer screening and diagnosis. Relying on proprietary algorithms, the software offers a true paradigm shift replacing human subjectivity with AI technological objectivity, self-learning, including improved accuracy and speed of delivery.
The ePathScreen software won the prestigious University Startup World Cup as the best in category as well as overall world winner, held in Denmark. The company is currently preparing for clinical trials with third-party validation preparatory to FDA approval, after which the software will be taken to market.
L.B. Dahle, CEO and Founder
After earning an undergraduate degree at Oklahoma State University in pre-med and international business, L.B. completed graduate studies in management, marketing and finance at OSU, Boise State, and international studies at Columbia University. He founded a company while in graduate school before transitioning to insurance. He was rapidly promoted and became area vice president and eventually president of an international division for PFSI, a $4 Billion insurance group (ultimately acquired by CONSECO), and thereafter Division President (domestic) for States General. He is a former Member, International Insurance Council.
After semi-retirement, he consulted with businesses under 100 Million in revenues in 16 different industries, ultimately founding his own consulting firm (LBDahle Enterprises) which he continues to operate. His consulting practice evolved into L.B. serving as interim or permanent CEO for different clients' companies. Since 2017 he has been affiliated with ePathScreen. He has a passion for health and fitness, having lost two family members and several close friends to cancer. L.B. is married with five children. He loves time with family, reading, research, analytics, travel, and sports of all kinds.
